Literature DB >> 17592361

Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.

Jennifer Z Bullock1, Joyce M Villanueva, Carine Blanchard, Alexandra H Filipovich, Philip E Putnam, Margaret H Collins, Kimberly A Risma, Rachel M Akers, Cassie L Kirby, Bridget K Buckmeier, Amal H Assa'ad, Simon P Hogan, Marc E Rothenberg.   

Abstract

BACKGROUND: Pediatric eosinophilic esophagitis (EE) is a recently described disorder associated with atopy. Although studies of esophageal tissue suggest that Th2 cytokines and eotaxin-3 may be crucial in disease pathogenesis, little is known about the systemic immunological phenotypes of children with EE.
OBJECTIVES: To define the phenotypes of peripheral blood eosinophils and lymphocytes in EE and to examine for correlations between these parameters and tissue eosinophil numbers and disease severity. PATIENTS AND METHODS: Blood was collected from children with EE, atopic control children without EE, and nonatopic control children without EE. Flow cytometry was used to measure eosinophil expression of chemokine receptor 3 (CCR3) and interleukin-5 receptor-alpha (IL-5Ralpha), and intracellular lymphocyte expression of IL-4, IL-5, IL-13, interferon-gamma, and tumor necrosis factor-alpha. Eosinophil numbers and eotaxin-3 mRNA levels were quantitated in esophageal biopsy specimens.
RESULTS: Compared with nonatopic control children, EE patients with active disease had increased peripheral blood eosinophil percentages, mean channel of fluorescence (MCF) of CCR3 on eosinophils, and percentage of CD4+ T cells expressing IL-5. Notably, these parameters positively correlated with esophageal eosinophil numbers. Eotaxin-3 tissue expression positively correlated with esophageal eosinophil numbers and peripheral blood eosinophil CCR3 MCF. The percentage of peripheral blood eosinophils, eosinophil CCR3 MCF, and CD4+ T cell expression of IL-5 were lower in EE patients in disease remission than in patients with active disease.
CONCLUSIONS: Collectively, these studies demonstrate cooperation between systemic CD4+ Th2-cell-mediated immunity and an enhanced eosinophil-CCR3/eotaxin-3 pathway in EE pathogenesis. Furthermore, the imbalanced Th2 immunity and increased CCR3 expression are reversible with disease remission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592361     DOI: 10.1097/MPG.0b013e318043c097

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  47 in total

Review 1.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

2.  Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.

Authors:  Daniel J Mulder; Aman Pooni; Nanette Mak; David J Hurlbut; Sameh Basta; Christopher J Justinich
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 3.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 4.  Eosinophilic esophagitis.

Authors:  Fouad J Moawad; Ganesh R Veerappan; Roy K Wong
Journal:  Dig Dis Sci       Date:  2009-06-25       Impact factor: 3.199

Review 5.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

6.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Authors:  Brittany T Hines; Matthew A Rank; Benjamin L Wright; Lisa A Marks; John B Hagan; Alex Straumann; Matthew Greenhawt; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2018-05-16       Impact factor: 6.347

7.  Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses.

Authors:  Calman Prussin; Joohee Lee; Barbara Foster
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 8.  Clinical spectrum of food allergies: a comprehensive review.

Authors:  Marco H-K Ho; Wilfred H-S Wong; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 9.  T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis?

Authors:  Zili Zhang; Thomas J Sferra; Yasemen Eroglu
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

10.  Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis.

Authors:  David W Morris; Emily M Stucke; Lisa J Martin; J Pablo Abonia; Vincent A Mukkada; Philip E Putnam; Marc E Rothenberg; Patricia C Fulkerson
Journal:  J Allergy Clin Immunol       Date:  2016-05-16       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.